Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Long-Term Deferred Tax (2016)

Apyx Medical's Long-Term Deferred Tax history spans 7 years, with the latest figure at $21000.0 for Q2 2016.

  • For Q2 2016, Long-Term Deferred Tax changed N/A year-over-year to $21000.0; the TTM value through Jun 2016 reached $21000.0, changed N/A, while the annual FY2015 figure was $25000.0, 99.54% down from the prior year.
  • Long-Term Deferred Tax reached $21000.0 in Q2 2016 per APYX's latest filing, down from $39000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $5.4 million in Q4 2014 to a low of $21000.0 in Q2 2016.
  • Average Long-Term Deferred Tax over 5 years is $2.1 million, with a median of $1.4 million recorded in 2012.
  • Peak YoY movement for Long-Term Deferred Tax: soared 66.87% in 2012, then crashed 99.54% in 2015.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $2.5 million in 2012, then skyrocketed by 35.5% to $3.4 million in 2013, then surged by 58.44% to $5.4 million in 2014, then plummeted by 99.54% to $25000.0 in 2015, then decreased by 16.0% to $21000.0 in 2016.
  • Per Business Quant, the three most recent readings for APYX's Long-Term Deferred Tax are $21000.0 (Q2 2016), $39000.0 (Q1 2016), and $25000.0 (Q4 2015).